| SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development N Murgolo, AG Therien, B Howell, D Klein, K Koeplinger, LA Lieberman, ... Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big …, 2021 | 239 | 2021 |
| MicroRNAs and HIV-1 infection: antiviral activities and beyond G Swaminathan, S Navas-Martín, J Martín-García Journal of molecular biology 426 (6), 1178-1197, 2014 | 136 | 2014 |
| A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages G Swaminathan, F Rossi, LJ Sierra, A Gupta, S Navas-Martín, ... Public Library of Science 8 (9), e1002937, 2012 | 132 | 2012 |
| A tetravalent sub-unit dengue vaccine formulated with ionizable cationic lipid nanoparticle induces significant immune responses in rodents and non-human primates G Swaminathan, EA Thoryk, KS Cox, JS Smith, JJ Wolf, ME Gindy, ... Scientific reports 6 (1), 34215, 2016 | 121 | 2016 |
| A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens G Swaminathan, EA Thoryk, KS. Cox, S Meschino, SA Dubey, KA Vora, R Celano ... Vaccine 34 (Issue 1), 110–119, 2016 | 110 | 2016 |
| Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid S Kortagere, N Madani, MK Mankowski, A Schön, I Zentner, ... Journal of virology 86 (16), 8472-8481, 2012 | 89 | 2012 |
| RNA viruses and microRNAs: challenging discoveries for the 21st century G Swaminathan, J Martin-Garcia, S Navas-Martin Physiological genomics 45 (22), 1035-1048, 2013 | 62 | 2013 |
| MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy A Gupta, G Swaminathan, J Martin-Garcia, S Navas-Martin Viruses 4 (11), 2485-2513, 2012 | 52 | 2012 |
| Adenovirus delivered short hairpin RNA targeting a conserved site in the 5′ non-translated region inhibits all four serotypes of dengue viruses AB Korrapati, G Swaminathan, A Singh, N Khanna, S Swaminathan Plos neglected tropical diseases 6 (7), e1735, 2012 | 30 | 2012 |
| Hepatitis C virus core protein enhances HIV-1 replication in human macrophages through TLR2, JNK, and MEK1/2-dependent upregulation of TNF-α and IL-6 G Swaminathan, D Pascual, G Rival, R Perales-Linares, J Martin-Garcia, ... FEBS letters 588 (18), 3501-3510, 2014 | 27 | 2014 |
| Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants S Awasthi, LM Hook, G Swaminathan, TM Cairns, B Brooks, JS Smith, ... Vaccine 37 (29), 3770-3778, 2019 | 23 | 2019 |
| Co-administration of lipid nanoparticles and sub-unit vaccine antigens is required for increase in antigen-specific immune responses in mice EA Thoryk, G Swaminathan, S Meschino, KS Cox, M Gindy, DR Casimiro, ... Vaccines 4 (4), 47, 2016 | 20 | 2016 |
| Bordetella bronchiseptica and Bordetella pertussis: similarities and differences in infection, immuno-modulation, and vaccine considerations B Miguelena Chamorro, K De Luca, G Swaminathan, S Longet, E Mundt, ... Clinical Microbiology Reviews 36 (3), e00164-22, 2023 | 15 | 2023 |
| Immunomodulation by the commensal microbiome during immune-targeted interventions: Focus on cancer immune checkpoint inhibitor therapy and vaccination AL Reens, DJ Cabral, X Liang, JE Norton Jr, AG Therien, DJ Hazuda, ... Frontiers in Immunology 12, 643255, 2021 | 12 | 2021 |
| Interplay between microRNAs, Toll-like receptors, and HIV-1: potential implications in HIV-1 replication and chronic immune activation G Swaminathan, S Navas-Martin, J Martin-Garcia Discovery medicine 18 (97), 15-27, 2014 | 12 | 2014 |
| Vaccine hyporesponse induced by individual antibiotic treatment in mice and non-human primates is diminished upon recovery of the gut microbiome G Swaminathan, M Citron, J Xiao, JE Norton Jr, AL Reens, BD Topçuoğlu, ... Vaccines 9 (11), 1340, 2021 | 11 | 2021 |
| Primary human dendritic cells and whole-blood based assays to evaluate immuno-modulatory properties of heat-killed commensal bacteria JE Norton Jr, S Kommineni, P Akrivoulis, DA Gutierrez, DJ Hazuda, ... Vaccines 9 (3), 225, 2021 | 7 | 2021 |
| A tetravalent sub-unit dengue vaccine formulated with ionizable cationic lipid nanoparticle induces significant immune responses in rodents and non-human primates. Sci Rep 6: 34215 G Swaminathan, EA Thoryk, KS Cox, JS Smith, JJ Wolf, ME Gindy, ... Toxicology 216, 106-121, 2016 | 6 | 2016 |
| Very early life microbiome and metabolome correlates with primary vaccination variability in children M Shaffer, K Best, C Tang, X Liang, S Schulz, E Gonzalez, CH White, ... Msystems 8 (5), e00661-23, 2023 | 5 | 2023 |
| Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine AM Izmirly, AN Pelletier, J Connors, B Taramangalam, SO Alturki, ... PLoS pathogens 18 (1), e1009903, 2022 | 4 | 2022 |
